Article Information
PubMed
Published By
History
- Received October 26, 2021
- Revision received April 3, 2022
- Accepted April 6, 2022
- First published April 18, 2022.
- Version of record published May 18, 2022.
Copyright & Usage
Copyright © 2022 the authors SfN exclusive license.
Author Information
- Shuo Zhang1,2,3,
- Bing Cai3,4,
- Zhen Li3,
- Kaikai Wang1,2,3,
- Lan Bao2,5,
- Changlin Li3,4,6, and
- Xu Zhang1,2,3,4
- 1Institute of Neuroscience and State Key Laboratory of Neuroscience, Center for Excellence in Brain Science and Intelligence Technology, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, China
- 2School of Life Science and Technology, ShanghaiTech University, Shanghai, 201210, China
- 3Research Unit of Pain Medicine, Chinese Academy of Medical Sciences; and SIMR Joint Lab of Drug Innovation, Shanghai Advanced Research Institute, Chinese Academy of Sciences; Shanghai Research Center for Brain Science and Brain-Inspired Intelligence, Shanghai, 201210, China
- 4Guangdong Institute of Intelligence Science and Technology, Hengqin, Zhuhai, 519031, China
- 5State Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, 200031, China
- 6Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, 518060, China
Author contributions
Author contributions: X.Z., S.Z., C.L., and L.B. designed research; S.Z., L.B., C.L., and X.Z. wrote the paper; S.Z., B.C., Z.L., and K.W. performed research; S.Z., B.C., Z.L., and K.W. analyzed data.
Disclosures
- Received October 26, 2021.
- Revision received April 3, 2022.
- Accepted April 6, 2022.
This work was supported by National Natural Science Foundation of China 32071001, 32192413, 31671094, and 32030050; Chinese Academy of Sciences QYZDYSSW-SMC007; Special Fund for Science-Technology Innovation Strategy of Guangdong Province 2021B0909050004; Science and Technology Commission of Shanghai Municipality 18JC1420301; Innovation Fund for Medical Sciences of Chinese Academy of Medical Sciences 2019-I2M-5-082; and Shenzhen Sanming Project.
The authors declare no competing financial interests.
- Correspondence should be addressed to Xu Zhang at zhangx{at}sari.ac.cn or Changlin Li at licl{at}gdiist.cn
Funding
National Natural Science Foundation of China (NSFC)
32071001; 31630033Chinese Academy of Sciences (CAS)
QYZDYSSW-SMC007the Strategic Priority Research Program of the Chinese Academy of Sciences
XDB39050100Science and Technology Commission of Shanghai Municipality (STCSM)
18JC1420301Innovation Fund for Medical Sciences of Chinese Academy of Medical Sciences
2019-I2M-5-082
Other Version
- previous version (April 18, 2022).
- You are viewing the most recent version of this article.
Online Impact
Article usage
In this issue
Fibroblastic SMOC2 Suppresses Mechanical Nociception by Inhibiting Coupled Activation of Primary Sensory Neurons
